about
Artesunate suppresses the viability and mobility of prostate cancer cells through UCA1, the sponge of miR-184Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know.Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels.Targeting Prostate Cancer Stem Cells with Alpha-Particle Therapy.Immunotherapeutics for the treatment of prostate cancer: a patent landscape based on key therapeutic mechanisms of actions.Polygodial analog induces apoptosis in LNCaP prostate cancer cells.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
New drugs in prostate cancer
@ast
New drugs in prostate cancer
@en
New drugs in prostate cancer
@nl
type
label
New drugs in prostate cancer
@ast
New drugs in prostate cancer
@en
New drugs in prostate cancer
@nl
prefLabel
New drugs in prostate cancer
@ast
New drugs in prostate cancer
@en
New drugs in prostate cancer
@nl
P2093
P2860
P3181
P1476
New drugs in prostate cancer
@en
P2093
Choung-Soo Kim
Dalsan You
Se Young Choi
P2860
P3181
P356
10.1016/J.PRNIL.2016.05.001
P407
P50
P577
2016-06-01T00:00:00Z